2001, Volume 3, Issue 4, pp 313-322
Tobacco smoking in patients with cardiovascular disease
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
- US Department of Health and Human Services: The health benefits of smoking cessation. A report of the Surgeon General. Atlanta: US Department of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health; 1990: DHHS publication no. (CDC) 90-8416. This Surgeon General’s report includes both disease specific and total mortality data on the benefits of smoking cessation, and includes excellent references.
- Benowitz NL, Gourlay SG: Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997, 29:1422–1431. This review covers cardiovascular effects of tobacco and nicotine, and the reasons to expect that nicotine replacement therapies are safer than smoking. CrossRef
- US Department of Health and Human Services: The health consequences of smoking: nicotine addiction. A report of the Surgeon General. Atlanta: US Department of Health and Human Services. Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health. 1988: DHHS Publication No. (PHS) (CDC) 88-8406. This Surgeon General report includes a detailed presentation of the evidence that nicotine creates physical dependence, and is responsible for most tobacco use.
- Fiore MC, Bailey WC, Cohen SJ, et al.: Treating tobacco use and dependence. Clinical practice guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service; 2000. This is the revision of the 1996 Agency for Health Care Policy and Research Smoking Cessation guideline. It uses meta-analytic techniques to comprehensively review and analyze the smoking cessation treatment literature through January 1, 1999. Excellent references are included for all treatment options.
- Thorndike AN, Rigotti NA, Stafford RS, et al.: National patterns in the treatment of smokers by physicians. JAMA 1998, 279:604–608. CrossRef
- Cromwell J, Bartosch WJ, Fiore MC, et al.: Cost-effectiveness of the clinical practice recommendations in the AHCPR Guideline for Smoking Cessation. Agency for Health Care Policy and Research. JAMA 1997, 278:1759–1766. CrossRef
- Curry SJ, Grothaus LC, McFee T, et al.: Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med 1998, 339:673–679. This paper describes the effect of insurance coverage for smoking cessation treatment and nicotine replacement products on intervention rates. CrossRef
- National Cancer Institute: Tobacco and the clinician: interventions for medical and dental practice. Monograph of National Cancer Institute 5, 1–22. 1994: NIH Publication No. 94-3693.
- Zhu SH, Strech V, Balabanis M, et al.: Telephone counseling for smoking cessation: effects of single session and multiple session interventions. J Consult Clin Psychol 1996, 64:202–211. CrossRef
- Joseph AM, Norman S, Ferry L, et al.: Safety of transdermal nicotine therapy in patients with cardiac disease: a randomized controlled trial. N Engl J Med 1996, 335:1792–1798. This paper describes the safety and efficacy of nicotine patches in a large, randomized, placebo-controlled trial in patients with CVD. CrossRef
- Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease: Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994, 154:989–995. CrossRef
- Tzivoni D, Keren A, Meyler S, et al.: Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther 1998, 12:239–244. CrossRef
- Murray RP, Bailey WC, Daniels K, et al.: Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Chest 1996, 109:428–445. A subset of patients in the Lung Health Study used nicotine gum up to 5 years. This study describes cardiovascular safety in this population.
- Covey LS, Glassman AH, Stetner F: Cigarette smoking and major depression. J Addict Dis 1998, 17:35–46. CrossRef
- Hurt RD, Eberman KM, Slade J, et al.: Treating nicotine addiction in patients with other addictive disorders. In Nicotine Addiction: Principles and Management. Edited by Orleans CT, Slade J. New York: Oxford; 1993:310–326.
- AhluwaliaJ, Gibson C, Kenney R, et al.: Smoking status as a vital sign. J Gen Intern Med 1999, 14:402–408. This article presents evidence about the systematic identification of smokers in the medical record and the effect of this practice on smoking cessation. CrossRef
- Prochaska J, Goldstein MG: Process of smoking cessation. Implications for clinicians. Clin Chest Med 1991, 12:727–735.
- Hatsukami D, Severson SG: Oral spit tobacco: addiction, prevention, and treatment. Nicotine Tob Res 1999, 1:21–44. This is a comprehensive review of patterns of use, nicotine dependence and treatment of chewing tobacco and oral snuff, with a complete set of references. CrossRef
- Henningfield JE: Nicotine medications for smoking cessation. N Engl J Med 1995, 333:1196–1203. CrossRef
- Tonnesen P, Paoletti P, Gustavsson G, et al.: Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Eur Resp J1999, 13:238–246. CrossRef
- Herrera N, Franco R, Herrera L, et al.: Nicotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program. Chest 1995, 108:447–451.
- Blondal T, Gudmundsson LJ, Olafsdottir I, et al.: Nicotine nasal spray with nicotine patch for smoking cessation: randomized trial with six year follow-up. BMJ 1999, 318:285–288.
- HurtRD, Sachs DP, Glover ED, et al.: A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997, 337:1195–1202. This is the original published trial demonstrating efficacy of bupropion as a smoking cessation aid. CrossRef
- JorenbyDE, Leischow SJ, Nides MA, et al.: A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999, 340:685–691. This is a clinical trial comparing the efficacy of bupropion, nicotine patches, both, or placebo for smoking cessation. CrossRef
- Glassman AH, Stetner F, Walsh BT, et al.: Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988, 259:2863–2866. CrossRef
- Hall SM, Reus VI, Munoz RF, et al.: Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998, 55:683–690. CrossRef
- Fagerstrom KO: Combined use of nicotine replacement products. Health Values 1994, 18:15–20.
- Puska P, Korhonen H, Vartiainen, et al.: Combined use of nicotine patch and gum compared with gum alone in smoking cessation: a clinical trial in North Karelia. Tob Control 1995, 4:231–235. CrossRef
- Abbot N, Stead L, White ABJ, et al.: Hypnotherapy for smoking cessation. In The Cochrane Library [electronic database]. Vista, CA; Update Software; 1999.
- Hughes JR: Applying harm reduction to smoking. Tob Control 1995, 4(suppl2):S33-S38.
- Tobacco smoking in patients with cardiovascular disease
Current Treatment Options in Cardiovascular Medicine
Volume 3, Issue 4 , pp 313-322
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links